Skip to main content
Log in

Osteoporosis in transplant recipients: initiate treatment as soon as possible

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Grotz W, Rump LC, Schollmeyer P. Osteoporosis in transplant recipients. Recommendations for avoidance and therapy. BioDrugs 1997 Jun; 7(6): 433–40

    Article  PubMed  CAS  Google Scholar 

  2. Diagnostic Laboratory Handbook, 2nd ed. Auckland; Adis International 1994 Mar; 220

  3. Valero MA, Loinaz C, Larrodera L, et al. Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int 1995; 57: 15–9

    Article  PubMed  CAS  Google Scholar 

  4. Meys F, Terreaux-Duvert F, Beaurne-Six T, et al. Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int 1993; 3: 322–9

    Article  PubMed  CAS  Google Scholar 

  5. Neuhaus R, Lohmann R, Platz KP, et al. Treatment of osteoporosis after liver transplantation. Transplant Proc 1995; 27: 1226–7

    PubMed  CAS  Google Scholar 

  6. Cleemput JV, Daenen W, Geusens P, et al. Prevention of bone loss in cardiac transplant patients: a comparison of bisphosphonates and vitamin D. Transplantation 1996; 61: 1495–9

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Osteoporosis in transplant recipients: initiate treatment as soon as possible. Drugs Ther. Perspect 10, 7–9 (1997). https://doi.org/10.2165/00042310-199710080-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710080-00002

Keywords

Navigation